Michelle Mello to United States
This is a "connection" page, showing publications Michelle Mello has written about United States.
Connection Strength
0.642
-
Public Health Law after Covid-19. N Engl J Med. 2021 09 23; 385(13):1153-1155.
Score: 0.033
-
Supporting Hospitals During a New Wave of COVID-19. J Hosp Med. 2021 May; 16(5):311-312.
Score: 0.033
-
When Physicians Engage in Practices That Threaten the Nation's Health. JAMA. 2021 Feb 23; 325(8):723-724.
Score: 0.032
-
The Missing Piece - SARS-CoV-2 Testing and School Reopening. N Engl J Med. 2020 Dec 03; 383(23):e126.
Score: 0.031
-
Attacks on Public Health Officials During COVID-19. JAMA. 2020 Aug 25; 324(8):741-742.
Score: 0.031
-
Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic. N Engl J Med. 2020 Sep 24; 383(13):e83.
Score: 0.031
-
Ensuring Uptake of Vaccines against SARS-CoV-2. N Engl J Med. 2020 Oct 01; 383(14):1296-1299.
Score: 0.031
-
Diagnostic Testing for the Novel Coronavirus. JAMA. 2020 Apr 21; 323(15):1437-1438.
Score: 0.030
-
Thinking Globally, Acting Locally - The U.S. Response to Covid-19. N Engl J Med. 2020 May 28; 382(22):e75.
Score: 0.030
-
Changes in Practice among Physicians with Malpractice Claims. N Engl J Med. 2019 Mar 28; 380(13):1247-1255.
Score: 0.028
-
Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues. N Engl J Med. 2018 Dec 13; 379(24):2290-2293.
Score: 0.028
-
HIPAA and Protecting Health Information in the 21st Century. JAMA. 2018 07 17; 320(3):231-232.
Score: 0.027
-
Behind Schedule - Reconciling Federal and State Marijuana Policy. N Engl J Med. 2018 Aug 09; 379(6):501-504.
Score: 0.027
-
Legal Barriers to the Growth of Health Information Exchange-Boulders or Pebbles? Milbank Q. 2018 03; 96(1):110-143.
Score: 0.026
-
Drug Companies' Liability for the Opioid Epidemic. N Engl J Med. 2017 Dec 14; 377(24):2301-2305.
Score: 0.026
-
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies. BMJ Open. 2017 Dec 05; 7(12):e017917.
Score: 0.026
-
Patients' Experiences With Communication-and-Resolution Programs After Medical Injury. JAMA Intern Med. 2017 11 01; 177(11):1595-1603.
Score: 0.026
-
The Evolving Story of Overlapping Surgery. JAMA. 2017 07 18; 318(3):233-234.
Score: 0.025
-
Medical Liability - Prospects for Federal Reform. N Engl J Med. 2017 May 11; 376(19):1806-1808.
Score: 0.025
-
Relationship Between State Malpractice Environment and Quality of Health Care in the United States. Jt Comm J Qual Patient Saf. 2017 05; 43(5):241-250.
Score: 0.025
-
Restrictions on the use of prescribing data for drug promotion. N Engl J Med. 2011 Sep 29; 365(13):1248-54.
Score: 0.017
-
Administrative compensation for medical injuries: lessons from three foreign systems. Issue Brief (Commonw Fund). 2011 Jul; 14:1-18.
Score: 0.017
-
Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis. BMJ Open. 2021 07 19; 11(7):e053248.
Score: 0.008
-
How US law will evaluate artificial intelligence for covid-19. BMJ. 2021 03 15; 372:n234.
Score: 0.008
-
The Legal Authority for States' Stay-at-Home Orders. N Engl J Med. 2020 Jul 30; 383(5):e29.
Score: 0.008
-
'Poking the skunk': Ethical and medico-legal concerns in research about patients' experiences of medical injury. Bioethics. 2019 10; 33(8):948-957.
Score: 0.007
-
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. Health Aff (Millwood). 2018 06; 37(6):964-974.
Score: 0.007